RxDoctor Payments Data

Bethany Snider, PA

Physician Assistant · Indianapolis, INNPI 1720484819

Payments from drug & device makers

$821in general payments, 2019–2025

Across 21 payments — averaging $39.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$124
  • E.r. Squibb & Sons, L.L.C.$110
  • Otsuka America Pharmaceutical, Inc.$106
  • Smith+Nephew$91
  • Novo Nordisk$90
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$55
  • plus $245 from 7 others

What the payments were for

  • Food & beverage$821100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$821 in reported general payments places this provider in the 70th percentile of 1,955 physician assistant providers in Indiana.

See all physician assistant providers in Indiana

Medicare billing

Part B allowed, 2024
$35,797
Medicare patients
135
Services billed
384

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban39$23,918
TrulicityDulaglutide13$14,509
JardianceEmpagliflozin16$12,567
XareltoRivaroxaban15$11,355
Spiriva HandihalerTiotropium Bromide12$6,367
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen70$1,736
Potassium Chloride71$1,450
Ondansetron OdtOndansetron17$1,392
Gabapentin91$1,304
Lantus SolostarInsulin Glargine,hum.Rec.Anlog11$1,115
Atorvastatin Calcium85$1,031
Duloxetine Hcl33$805
Metoprolol Succinate74$772
Levothyroxine Sodium60$675
Tamsulosin Hcl28$666

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$17$12,56716 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,955 physician assistant providers in Indiana.

Other physician assistant in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →